Indefinite Delivery Contract 36C26226D0069

Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. headquartered in Dublin, Ohio, has been awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 22 (VISN 22) with a ceiling value of $258,908.72 and a period of performance from April 1, 2026, through March 31, 2031. The contract procures 99mTC Tilmanocept (Lymphoseek), a specialized nuclear medicine radiopharmaceutical used for lymph node localization in surgical and oncological procedures. This sole-source procurement, justified under Federal Acquisition Regulation Part 6, reflects Cardinal Health 414's exclusive manufacturing and distribution rights for Lymphoseek in the United States. The contract is structured as a firm fixed-price vehicle with no set-asides, supporting the nuclear medicine and diagnostic imaging requirements across VA medical centers within VISN 22's service area. Performance will occur at Cardinal Health 414's primary facility in Dublin, Ohio, ensuring regulatory compliance with Nuclear Regulatory Commission licensing and Food and Drug Administration approval requirements for radiopharmaceutical distribution.

Two delivery orders have been issued under this Indefinite Delivery Contract as of the initial award date: a base delivery order for the Phoenix VA Medical Center valued at $25,938.01 (25 units annually through March 31, 2027) and a base delivery order for the San Diego VA Medical Center valued at $20,917.75 (equivalent annual requirements through March 31, 2027). These orders establish initial procurement requirements for the base contract period, with four optional one-year renewal periods extending through March 31, 2031, providing flexible procurement authority to accommodate both routine scheduled deliveries and emergency orders necessitated by the short half-life characteristics of radioactive isotopes. The firm fixed-price structure ensures cost certainty for the Department of Veterans Affairs while maintaining Cardinal Health 414's established role as a critical single-source supplier for essential nuclear medicine diagnostic imaging support across the federal healthcare system.